Joshua Woolard, MD
Interventional Pain Medicine · Edmond, OKNPI 1942620604
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,259 of the $7,257 with a category attached, or 86.2%. 27 manufacturers reported payments, led by Nevro Corp. at 44.3% of the total. Reporting peaked in 2020 at $2,436 and has fallen 63.8% since, to $882 in 2025.
Across 254 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$3K
- Abbott$1K
- Medtronic$720
- Saluda Medical Americas, Inc.$463
- AbbVie$323
- Vertiflex, Inc.$149
- plus $979 from 21 others
What the payments were for
- Consulting fees$1252%
- Travel & lodging$81511%
- Food & beverage$6,25986%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 65 | $3,215 |
| Abbott | 77 | $1,409 |
| Medtronic(2 entities) | 22 | $720 |
| Saluda Medical Americas, Inc. | 15 | $463 |
| AbbVie(2 entities) | 18 | $323 |
| Vertiflex, Inc. | 1 | $149 |
| Scilex Pharmaceuticals Inc. | 8 | $146 |
| Amgen(2 entities) | 9 | $129 |
| SPR Therapeutics, Inc | 8 | $109 |
| Boston Scientific | 3 | $73 |
| Averitas Pharma Inc. | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Almatica Pharma LLC | 4 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Curonix LLC | 1 | $33 |
| Merck | 2 | $32 |
| Bioventus LLC | 2 | $30 |
| Avanos Medical | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Vertex | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Nalu Medical, Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$1,246
- INCEPTIV$365
- Neuromodulation Dspsbls and Accs$271
- Evoke SCS$176
- Superion ISS$149
- Omnia$130
- Senza$127
How this compares
$7,257 in reported general payments places this provider in the 80th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 409 | $8,401 |
| Buprenorphine | 18 | $3,586 |
| Gabapentin | 242 | $3,143 |
| Pregabalin | 100 | $2,239 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 75 | $1,765 |
| Fentanyl | 14 | $1,251 |
| Duloxetine Hcl | 40 | $748 |
| Tramadol Hcl | 97 | $543 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $507 |
| Cyclobenzaprine Hcl | 34 | $440 |
| Oxycodone Hcl | 13 | $397 |
| Tizanidine Hcl | 32 | $358 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $215 |
| Hydromorphone Hcl | 14 | $212 |
| Meloxicam | 33 | $94 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Edmond
- Amer NouhEdmond$8K
- Sterling RiggsEdmond$638
- Gentian MetaEdmond$174
- Brandon ValantineOklahoma City$9K
- Muhammad MaqboolTulsa$8K
- Justin PorterOklahoma City$8K
- Samuel KorbeTulsa$7K
- Michael McLaughlinMoore$7K
- Steve RandallMidwest City$6K
- Blake ChristensenOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.